AO "FARMAMED", Moscow

Economic indicators

Net profit (RAS) of AO FARMAMED dropped in 2022 by 30.22% to 1.52 billion RUB from 2.17 billion RUB over the same period in 2021, the company informed.

Revenue increased in the accounting period by 12.55% to 4.76 billion RUB from 4.23 billion RUB over 2021; cost of goods sold decreased by 7.03% to 1.09 billion RUB from 1.18 billion RUB; sales profit went up by 34.14% to 2.49 billion RUB from 1.86 billion RUB.

Net profit (RAS) of AO FARMAMED grew over 2021 10.84 times to 2.17 billion RUB from 200.49 million RUB over 2020, the company informed.

Revenue increased in the accounting period by 30.62% to 4.23 billion RUB from 3.24 billion RUB over 2020; cost of goods sold grew by 27.57% to 1.18 billion RUB from 921.84 million RUB; sales profit went up by 35.24% to 1.86 billion RUB from 1.38 billion RUB.

Net profit (RAS) of AO FARMAMED dropped in 2020 2.98 times to 200.49 million RUB from 597.41 million RUB over the same period in 2019, the company informed.

Revenue increased in the accounting period by 34.71% to 3.24 billion RUB from 2.40 billion RUB over 2019; cost of goods sold grew by 36.39% to 921.84 million RUB from 675.89 million RUB; sales profit went up 1.70 times to 1.38 billion RUB from 810.36 million RUB.

Net profit (RAS) of AO FARMAMED made up 1.91 billion RUB over 2019 compared to net loss of 50.28 million RUB over 2018, the company informed.

Revenue increased in the accounting period by 21.20% to 2.50 billion RUB from 2.06 billion RUB over 2018; cost of goods sold grew by 27.11% to 683.90 million RUB from 538.02 million RUB; sales profit went up by 8.44% to 796.94 million RUB from 734.88 million RUB.

Net loss (RAS) of AO FARMAMED dropped over 2018 56.43 times to 50.28 million RUB from 2.84 billion RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period by 10.48% to 2.06 billion RUB from 1.86 billion RUB over 2017; cost of goods sold grew by 6.04% to 538.02 million RUB from 507.36 million RUB; sales profit went up by 1.60% to 734.88 million RUB from 723.32 million RUB.

Net loss (RAS) of AO FARMAMED dropped over 2017 by 5.90% to 461.70 million RUB from 490.65 million RUB KAgent.Entities.Balance, the company informed.

Revenue decreased in the accounting period by 16.15% to 1.86 billion RUB from 2.22 billion RUB in 2016; cost of goods sold decreased by 49.35% to 507.36 million RUB from 1.00 billion RUB; sales profit went up by 35.52% to 723.32 million RUB from 533.72 million RUB.

Net loss (RA) of AO FARMAMED made up 490.65 million RUB over 2016 compared to net profit of 54.91 million RUB over 2015, the company informed.

Revenue increased in the accounting period by 3.61% to 2.22 billion RUB from 2.15 billion RUB over 2015; cost of goods sold decreased by 43.34% to 1.00 billion RUB from 1.77 billion RUB; sales profit made up 533.72 million RUB compared to sales loss of 177.89 million RUB.

Net profit (RAS) of Farmamed, ZAO made up 9.88 million RUB over 2013 compared to net loss of 1.31 million RUB over 2012, the company informed.

Revenue increased in the accounting period by 46.94% to 2.76 billion RUB from 1.88 billion RUB over 2012; cost of goods sold grew by 35.18% to 1.95 billion RUB from 1.45 billion RUB; sales profit went up 2.69 times to 405.68 million RUB from 150.83 million RUB.

Net loss (RA) of FARMAMED, ZAO made up 1.31 million RUB over 2012 compared to net profit of 17.48 million RUB over 2011, the company informed.

Cost of goods sold grew 1.54 times to 1.45 billion RUB from 940.81 million RUB; sales profit fell by 18.84% to 150.83 million RUB from 185.86 million RUB.

Companies in the region

• GUM-KRASANA
• KORDIS MEDIA
• AO "PI"
• AO "FERROTEK NORD"
• DIAL